37.25
前日終値:
$38.02
開ける:
$37.82
24時間の取引高:
549.59K
Relative Volume:
1.39
時価総額:
$1.84B
収益:
$345.60M
当期純損益:
$-79.01M
株価収益率:
-23.22
EPS:
-1.6045
ネットキャッシュフロー:
$-18.62M
1週間 パフォーマンス:
+1.78%
1か月 パフォーマンス:
+32.75%
6か月 パフォーマンス:
+18.18%
1年 パフォーマンス:
-12.74%
Immunocore Holdings Plc Adr Stock (IMCR) Company Profile
名前
Immunocore Holdings Plc Adr
セクター
電話
01235 5430281
住所
90 PARK DRIVE, OXFORDSHIRE
IMCR を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
IMCR
Immunocore Holdings Plc Adr
|
37.25 | 1.84B | 345.60M | -79.01M | -18.62M | -1.6045 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 113.52B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 52.93B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
300.83 | 39.71B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
585.93 | 35.00B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunocore Holdings Plc Adr Stock (IMCR) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-05-27 | 開始されました | Deutsche Bank | Buy |
2024-12-13 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2024-11-11 | ダウングレード | Mizuho | Outperform → Neutral |
2024-10-24 | 開始されました | UBS | Sell |
2024-10-07 | ダウングレード | Guggenheim | Buy → Neutral |
2024-04-29 | 開始されました | Leerink Partners | Outperform |
2023-11-20 | 再開されました | JP Morgan | Overweight |
2023-11-02 | 開始されました | Cantor Fitzgerald | Overweight |
2023-10-31 | 開始されました | Robert W. Baird | Outperform |
2023-09-13 | アップグレード | JP Morgan | Neutral → Overweight |
2023-09-13 | 開始されました | Needham | Buy |
2023-08-16 | 開始されました | CapitalOne | Overweight |
2023-07-17 | 開始されました | Canaccord Genuity | Hold |
2023-03-31 | 開始されました | Mizuho | Buy |
2023-03-30 | 開始されました | Guggenheim | Buy |
2023-03-24 | 開始されました | Bryan Garnier | Buy |
2022-12-16 | アップグレード | Goldman | Neutral → Buy |
2022-11-30 | 開始されました | Barclays | Overweight |
2022-09-09 | 開始されました | Morgan Stanley | Overweight |
2022-09-08 | 開始されました | Ladenburg Thalmann | Buy |
2022-08-08 | 開始されました | Cowen | Outperform |
2022-08-02 | 開始されました | BTIG Research | Buy |
2022-02-08 | 開始されました | H.C. Wainwright | Buy |
2021-10-20 | 開始されました | Oppenheimer | Outperform |
2021-03-02 | 開始されました | Goldman | Neutral |
2021-03-02 | 開始されました | JP Morgan | Overweight |
2021-03-02 | 開始されました | Jefferies | Buy |
すべてを表示
Immunocore Holdings Plc Adr (IMCR) 最新ニュース
Immunocore at Jefferies Global Healthcare Conference: Strong Growth and Promising Trials - Investing.com India
Wall Street Analysts Think Immunocore (IMCR) Could Surge 65.22%: Read This Before Placing a Bet - sharewise
Deutsche Bank sets $65 target on Immunocore stock, rates Buy By Investing.com - Investing.com India
Deutsche Bank sets $65 target on Immunocore stock, rates Buy - Investing.com
Immunocore’s SWOT analysis: biotech firm’s stock faces challenges amid growth - Investing.com
Is it a Good Idea to Invest in Immunocore Stock Right Now? - MSN
Wall Street Analysts See an 114.35% Upside in Immunocore (IMCR): Can the Stock Really Move This High? - MSN
Balance Sheet Dive: Hippo Holdings Inc (HIPO)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX
Analyzing Ratios: Symbotic Inc (SYM)’s Financial Story Unveiled - DWinneX
New Strong Buy Stocks for May 8th - The Globe and Mail
Immunocore stock rises as Q1 results top estimates By Investing.com - Investing.com South Africa
Immunocore stock rises as Q1 results top estimates - Investing.com
Immunocore Holdings earnings beat by $0.49, revenue topped estimates - Investing.com
Compared to Estimates, Immunocore (IMCR) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
ESPR's Q1 Earnings Miss Estimates, Revenues Beat, Stock Down - Barchart.com
AXSM Q1 Loss Narrower Than Expected, Auvelity Drives Revenues Y/Y - The Globe and Mail
Agios' Q1 Loss Narrower Than Expected, Revenues Lag Estimates - Barchart.com
Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y - Barchart.com
Wall Street Analysts Think Immunocore (IMCR) Could Surge 107.45%: Read This Before Placing a Bet - Yahoo Finance
Mizuho cuts Immunocore stock price target to $33 from $38 - Investing.com
Immunocore stock hits 52-week low at $27.19 amid market challenges By Investing.com - Investing.com South Africa
Immunocore stock hits 52-week low at $27.19 amid market challenges - Investing.com
Do investors need to be concerned about Immunocore Holdings plc ADR (IMCR)? - US Post News
Immunocore (IMCR) Moves 6.0% Higher: Will This Strength Last? - MSN
Immunocore holdings sees $23.99 million in stock purchases by Baker Bros - Investing.com South Africa
Immunocore amends senior notes indenture, files prospectus - Investing.com India
Immunocore amends senior notes indenture, files prospectus By Investing.com - Investing.com South Africa
H.C. Wainwright maintains $100 target on Immunocore stock - Investing.com
Immunocore’s SWOT analysis: biotech firm’s stock outlook amid HIV and cancer drug progress - Investing.com
BTIG maintains Immunocore stock Buy rating, $91 target - Investing.com
Immunocore stock hits 52-week low at $27.59 amid market challenges - Investing.com
Immunocore reports promising HIV trial results By Investing.com - Investing.com South Africa
Immunocore reports promising HIV trial results - Investing.com India
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025 - GlobeNewswire Inc.
Immunocore at TD Cowen Conference: Strategic Growth and Innovation - Investing.com India
Immunocore at TD Cowen Conference: Strategic Growth and Innovation By Investing.com - Investing.com South Africa
PBYI Stock Rises as Q4 Earnings & Sales Outpace EstimatesFebruary 28, 2025 - Zacks Investment Research
Earnings call transcript: Immunocore Holdings Q4 2024 misses EPS - Investing.com
Immunocore Holdings earnings missed by $0.23, revenue fell short of estimates - Investing.com
United Therapeutics Stock Down Despite Q4 Earnings & Sales Beat - Yahoo Finance
Bausch Health Beats on Q4 Earnings and Revenues, Xifaxan Boosts Sales - Yahoo Finance
Immunocore Gears Up to Report Q4 Earnings: Is a Beat in Store? - MSN
A stock that deserves closer examination: Empresa Distribuidora y Comercial Norte S.A. ADR (EDN) - US Post News
I-Mab ADR (IMAB) stock analysis: A simple moving average approach - US Post News
A closer look at Inhibrx Biosciences Inc (INBX)’s stock price trends - US Post News
Immunocore Holdings Plc Adr (IMCR) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):